Imexpharm set growth record in 2023
April 02, 2024 | 08:00
Imexpharm Corporation announced its business results on March 27, for the fiscal year ending December 31, 2023.
SK Investment Vina III to hold 65 per cent of Imexpharm
December 28, 2023 | 11:20
SK Investment Vina III, a subsidiary of South Korea’s third-largest conglomerate SK Group, is looking to acquire a 65 per cent stake in Imexpharm Pharmaceutical.
Imexpharm raises its status with EU-GMP-standard factories
November 25, 2023 | 17:38
With the largest pharmaceutical production lines that meet European standards (EU-GMP) in Vietnam, Imexpharm has great potential to become an industry leader.
DKSH, Hoa Linh, and Thai Minh partner up on development journey
August 07, 2023 | 17:40
DKSH, Hoa Linh Pharmaceutical, and Thai Minh Pharmaceutical reveal development and expansion plans that go far into the future.
Vietnamese companies reject illegal wild species-based ingredients and products
July 22, 2023 | 08:00
30 companies from Vietnam have committed to stamping out illegal wild species ingredients in their manufacturing and sales of traditional medicines (TM).
MPI calls on investors to make suggestions in pharma sector
July 20, 2023 | 16:40
The Ministry of Planning and Investment has called on investors and manufacturers to contribute opinions and proposals to attract more investment capital and receive technology transfer to promote the development of the pharmaceutical sector of Vietnam.
More than 200 participants join VIR's conference on pharma and medical sector
July 20, 2023 | 09:30
Over 200 attendees gathered at the conference to discuss the importance of Resolution No.29-NQ/TW to the sustainable development of Vietnam’s health system.
Retail businesses see potential in pharmaceutical retail
January 09, 2023 | 15:28
In the context of rising inflation, many retail businesses can continue to grow thanks to bolstering their activities in the pharmaceutical sector.
Bayer’s Pharma Business in Asia-Pacific drives growth
April 22, 2022 | 13:34
Bayer announced that 2021 was another record year for its Pharmaceuticals division in the Asia-Pacific region, with robust growth of 4.8 per cent delivering sales of more than $6.3 billion.
Innovating Vietnam's pharmaceutical sector
April 21, 2022 | 14:33
Shareholders and investors highly appreciate Traphaco's progress in innovation and creativity, especially its corporate restructuring strategy.
Pharma rules unable to stand test of time
July 16, 2021 | 12:12
After four years of enforcement of certain pharmaceutical rules, multinational corporations remain concerned and are changing operations in Vietnam, with import being one of the main focuses.
Mitigating procedural delays in pharmaceutical market
July 12, 2021 | 13:00
While Vietnam has witnessed positive developments in the pharmaceutical and healthcare spheres over the past few years, some issues still need to be ironed out.
International investors scoop up major stakes in drugmakers
June 30, 2021 | 14:20
Dealmaking and investment in pharmaceutical and healthcare businesses are increasing in scope as investors are vying for the controlling stake of key players.
Local pharma sector to benefit from EU connection
February 07, 2021 | 08:00
Despite lower-than-expected growth, Vietnam’s pharmaceutical market performed better than other global markets in the past 12 months. Magdalena Krakowiak, chairwoman of the International Quality Medicines’ Generic and Biosimilar Sector Committee (IQMED) at the European Chamber of Commerce in Vietnam, writes about 2020 results and future prospects thanks to the EU-Vietnam Free Trade Agreement.
The prescription for 2021 – to invest in high quality and give back to society
December 28, 2020 | 09:00
In 2020, Vietnam’s pharmaceutical market is estimated to have grown by around 4 per cent compared to the previous year, according to healthcare data multinational IQVIA. The market is expected to continue growing significantly in terms of both capacity and value thanks to the country’s population size of nearly 100 million people, improved access to healthcare, and the government’s efforts to promote universal health insurance.
Mobile Version